BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 22628315)

  • 1. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.
    Nacken W; Ehrhardt C; Ludwig S
    Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of c-Jun terminal kinase (JNK) activation in influenza A virus-induced autophagy and replication.
    Zhang J; Ruan T; Sheng T; Wang J; Sun J; Wang J; Prinz RA; Peng D; Liu X; Xu X
    Virology; 2019 Jan; 526():1-12. PubMed ID: 30316042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
    Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus.
    Haasbach E; Reiling SJ; Ehrhardt C; Droebner K; Rückle A; Hrincius ER; Leban J; Strobl S; Vitt D; Ludwig S; Planz O
    Antiviral Res; 2013 Sep; 99(3):336-44. PubMed ID: 23811282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of c-jun N-terminal kinase upon influenza A virus (IAV) infection is independent of pathogen-related receptors but dependent on amino acid sequence variations of IAV NS1.
    Nacken W; Anhlan D; Hrincius ER; Mostafa A; Wolff T; Sadewasser A; Pleschka S; Ehrhardt C; Ludwig S
    J Virol; 2014 Aug; 88(16):8843-52. PubMed ID: 24872593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo.
    Droebner K; Pleschka S; Ludwig S; Planz O
    Antiviral Res; 2011 Nov; 92(2):195-203. PubMed ID: 21854809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The c-Jun N-terminal kinase inhibitor SP600125 inhibits human cytomegalovirus replication.
    Zhang H; Niu X; Qian Z; Qian J; Xuan B
    J Med Virol; 2015 Dec; 87(12):2135-44. PubMed ID: 26058558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance.
    Ehrhardt C; Hrincius ER; Korte V; Mazur I; Droebner K; Poetter A; Dreschers S; Schmolke M; Planz O; Ludwig S
    Antiviral Res; 2007 Oct; 76(1):38-47. PubMed ID: 17572513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of influenza A virus by mixed siRNAs, targeting the PA, NP, and NS genes, delivered by hybrid microcarriers.
    Brodskaia AV; Timin AS; Gorshkov AN; Muslimov AR; Bondarenko AB; Tarakanchikova YV; Zabrodskaya YA; Baranovskaya IL; Il'inskaja EV; Sakhenberg EI; Sukhorukov GB; Vasin AV
    Antiviral Res; 2018 Oct; 158():147-160. PubMed ID: 30092251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin A1 inhibits avian influenza virus replication at a postentry level: Effect on virus protein synthesis and NF-κB activity.
    Carta S; La Frazia S; Donatelli I; Puzelli S; Rossi A; Santoro MG
    Prostaglandins Leukot Essent Fatty Acids; 2014 Dec; 91(6):311-23. PubMed ID: 25151089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of Avian-Origin PB1 Facilitates Viral RNA Synthesis by the 2009 Pandemic H1N1 Virus Polymerase.
    Wang F; Liu G; Lu Y; Hlasny M; Liu Q; Zhou Y
    Viruses; 2020 Feb; 12(3):. PubMed ID: 32121117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small interfering RNA targeting the nonstructural gene 1 transcript inhibits influenza A virus replication in experimental mice.
    Rajput R; Khanna M; Kumar P; Kumar B; Sharma S; Gupta N; Saxena L
    Nucleic Acid Ther; 2012 Dec; 22(6):414-22. PubMed ID: 23062009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small molecule multi-kinase inhibitor reduces influenza A virus replication by restricting viral RNA synthesis.
    Martinez-Gil L; Alamares-Sapuay JG; Ramana Reddy MV; Goff PH; Premkumar Reddy E; Palese P
    Antiviral Res; 2013 Oct; 100(1):29-37. PubMed ID: 23891991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chicken interferon alpha pretreatment reduces virus replication of pandemic H1N1 and H5N9 avian influenza viruses in lung cell cultures from different avian species.
    Jiang H; Yang H; Kapczynski DR
    Virol J; 2011 Sep; 8():447. PubMed ID: 21939525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Short Form of the Zinc Finger Antiviral Protein Inhibits Influenza A Virus Protein Expression and Is Antagonized by the Virus-Encoded NS1.
    Tang Q; Wang X; Gao G
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential localization and function of PB1-F2 derived from different strains of influenza A virus.
    Chen CJ; Chen GW; Wang CH; Huang CH; Wang YC; Shih SR
    J Virol; 2010 Oct; 84(19):10051-62. PubMed ID: 20660199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.
    Yuan S; Chu H; Zhao H; Zhang K; Singh K; Chow BK; Kao RY; Zhou J; Zheng BJ
    Antiviral Res; 2016 Jan; 125():34-42. PubMed ID: 26593979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The c-Jun N-terminal kinase (JNK) is involved in H5N1 influenza A virus RNA and protein synthesis.
    Zhang S; Tian H; Cui J; Xiao J; Wang M; Hu Y
    Arch Virol; 2016 Feb; 161(2):345-51. PubMed ID: 26559961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel p38 mitogen activated protein kinase (MAPK) specific inhibitor suppresses respiratory syncytial virus and influenza A virus replication by inhibiting virus-induced p38 MAPK activation.
    Choi MS; Heo J; Yi CM; Ban J; Lee NJ; Lee NR; Kim SW; Kim NJ; Inn KS
    Biochem Biophys Res Commun; 2016 Aug; 477(3):311-6. PubMed ID: 27346133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
    Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
    Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.